• Viperin Disrupts Coronavirus Replication via nsp8 and ddhCTP

  2026-07-15

  This study uncovers a dual antiviral mechanism by which viperin inhibits coronavirus replication: direct interference with the viral replication-transcription complex via binding to non-structural protein 8 (nsp8), and enzymatic production of ddhCTP, a nucleotide analog that terminates viral RNA synthesis in susceptible coronaviruses. These findings provide a molecular basis for broad-spectrum RNA virus replication inhibition and highlight new targets for antiviral drug development.

• Polygodial and TRPA1: Decoding Ion Channel Signaling in Sens

  2026-07-15

  Explore the multifaceted role of Polygodial as a TRPA1 channel activator in sensory ion channel research. This article offers an in-depth, evidence-based perspective on molecular mechanisms, translational assay design, and new frontiers in neuroepithelial signaling.

• Applied Workflows with BGJ398 (NVP-BGJ398) in FGFR Research

  2026-07-14

  BGJ398 (NVP-BGJ398) sets the benchmark for selective FGFR targeting, enabling high-confidence dissection of FGFR-driven malignancies and developmental pathways. Discover protocol refinements, troubleshooting strategies, and key translational insights for maximizing success in oncology research and organogenesis models.

• Spermine as a Precision Tool: Decoding Polyamine Regulation

  2026-07-14

  Explore how spermine, a pivotal endogenous polyamine, uniquely regulates membrane excitability and nuclear envelope dynamics in eukaryotic cells. This article provides advanced insight into spermine’s mechanistic role, its practical impact on cellular assays, and how new discoveries in nuclear membrane fusion redefine ion channel research.

• Anagliptin-Induced Vasorelaxation: Roles of Kv Channels and

  2026-07-13

  The 2025 Acta Diabetologica study provides the first direct mechanistic evidence that Anagliptin (SK-0403) induces vasorelaxation in rabbit aorta via activation of voltage-dependent K+ (Kv) channels and SERCA pump, independent of endothelium or classical cAMP/cGMP pathways. These findings clarify vascular actions of this DPP-4 inhibitor, informing research design in diabetes and cardiovascular disease.

• Anagliptin (SK-0403): Protocols for Vascular and DPP-4 Resea

  2026-07-13

  Anagliptin (SK-0403) bridges DPP-4 inhibition with direct vascular modulation, enabling advanced workflows for diabetes and cardiovascular research. This guide translates the latest mechanistic insights into practical protocols, troubleshooting, and assay design.

• Canagliflozin as an SGLT2 Inhibitor: Optimizing Renal Resear

  2026-07-12

  Canagliflozin empowers translational diabetes and nephrology research by enabling precise SGLT2 inhibition and revealing mitochondrial mechanisms underlying kidney protection. This article delivers actionable protocol guidance, troubleshooting strategies, and a data-driven synthesis of recent mitochondrial findings for advanced metabolic disease studies.

• Moesin as a Biomarker of Endothelial Injury in Sepsis: Evide

  2026-07-10

  The referenced study identifies moesin as a novel biomarker that reflects endothelial injury severity in sepsis. By linking increased serum moesin to disrupted vascular integrity and inflammatory signaling, the research offers new mechanistic insights and experimental opportunities for sepsis and cardiovascular studies.

• Adipose-Neural Axis Drives Cardiac Arrhythmias via Leptin-NP

  2026-07-09

  Fan et al. reveal that the adipose-neural axis mechanistically links epicardial adipose tissue to cardiac arrhythmias through leptin and neuropeptide Y (NPY) signaling. Their stem cell-based coculture model uncovers new molecular targets and provides a foundation for therapeutic interventions in arrhythmia.

• ATP in Translational Strategy: Beyond Energy to Enzyme Contr

  2026-07-09

  Adenosine triphosphate (ATP) is universally recognized as the cell's primary energy carrier, yet its roles transcend bioenergetics—encompassing direct signaling and nuanced regulation of mitochondrial metabolism. This thought-leadership piece synthesizes mechanistic discoveries, such as TCAIM-mediated post-translational control of the TCA cycle, with strategic guidance for translational researchers. We elucidate how leveraging high-purity ATP from APExBIO (SKU C6931) can elevate cellular metabolism research, enable advanced purinergic receptor studies, and unlock new investigative frontiers in disease modeling.

• 5-(N,N-dimethyl)-Amiloride Hydrochloride: Unraveling Endothe

  2026-07-08

  Explore the unique role of 5-(N,N-dimethyl)-Amiloride hydrochloride in dissecting intracellular pH regulation and endothelial function during sepsis. This in-depth analysis advances beyond standard protocols to reveal how targeted inhibition of Na+/H+ exchangers refines experimental modeling and biomarker discovery.

• D-Luciferin (Potassium Salt): Transforming Tumor Tracking in

  2026-07-08

  Explore how D-Luciferin (potassium salt) empowers translational researchers to non-invasively monitor tumor cell dynamics, optimize CAR T cell therapies, and set new standards in in vivo bioluminescence imaging. This thought-leadership article integrates mechanistic insight, strategic guidance, and evidence from pivotal studies to illuminate best practices and future opportunities.

• Pazopanib Hydrochloride: Reliable Solutions for Cancer Resea

  2026-07-07

  This article addresses key challenges in cell-based oncology workflows and demonstrates, with scenario-driven evidence, how Pazopanib Hydrochloride (SKU A8347) enables reproducible, data-backed assays. Researchers will find practical guidance for protocol optimization, data interpretation, and reliable product selection, enhancing their cancer research outcomes.

• Polygodial in TRPA1 Research: Mechanistic Insight and Assay

  2026-07-07

  Explore how Polygodial, a TRPA1 channel activator, enables nuanced studies of membrane transporter signaling and sensory neuron pathways. This article uniquely dissects mechanistic findings and assay best practices, advancing beyond standard protocols.

• 5-(N,N-dimethyl)-Amiloride Hydrochloride: Ion Transport and

  2026-07-06

  5-(N,N-dimethyl)-Amiloride hydrochloride is a potent Na+/H+ exchanger inhibitor used for precise modulation of intracellular pH and protection against ischemia-reperfusion injury. Recent evidence underscores its specificity for NHE1, NHE2, and NHE3, enabling advanced research into cardiac and endothelial pathophysiology. Supplied by APExBIO, this reagent is fundamental in dissecting Na+/H+ exchanger signaling pathways while presenting clear boundaries in application.

15887 records 1/1060 page Next 12345 下5页 Last page